flupirtine has been researched along with carbamates in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (40.00) | 29.6817 |
2010's | 10 (50.00) | 24.3611 |
2020's | 2 (10.00) | 2.80 |
Authors | Studies |
---|---|
Evert, BO; Klockgether, T; Kovar, KA; Rundfeldt, C; Schulz, JB; Seyfried, J; Wüllner, U | 1 |
Lawson, K | 1 |
Annunziato, L; Castaldo, P; D'Amico, M; Martire, M; Preziosi, P; Taglialatela, M | 1 |
Dworetzky, SI; Wua, YJ | 1 |
Annunziato, L; Boscia, F; Taglialatela, M | 1 |
Greenwood, IA; Moffatt, JD; Ohya, S; Pucovský, V; Saldanha, L; Schwake, M; Yeung, SY | 1 |
Martire, M; Miceli, F; Soldovieri, MV; Taglialatela, M | 1 |
Greenwood, Ia; Pucovský, V; Schwake, M; Yeung, S | 1 |
England, SK; Greenwood, IA; McCallum, LA; Pierce, SL; Tribe, RM | 1 |
Brueggemann, LI; Byron, KL; Cribbs, LL; Dowell, ML; Kakad, PP; Love, RB; Solway, J | 1 |
Hamann, M; Lange, N; Lemm, C; Richter, A; Sander, SE | 1 |
Gamper, N; Huang, D; Linley, JE; Pettinger, L | 1 |
King, AE; Visockis, V | 1 |
Adduci, A; Arena, V; Coco, C; Currò, D; Martire, M; Rizzo, G; Taglialatela, M | 1 |
Guo, L; Huang, P; Li, C; Lu, Q; Xu, X; Zhou, M | 1 |
Ambrosino, P; Barrese, V; Breschi, MC; Calderone, V; Canduela, MJ; Curtis, MJ; Grandes, P; Greenwood, IA; Martelli, A; Miceli, F; Scorziello, A; Sisalli, MJ; Soldovieri, MV; Taglialatela, M; Testai, L; Vinciguerra, I | 1 |
Lopez-Garcia, JA; Rivera-Arconada, I; Vicente-Baz, J | 1 |
Burris, KD; Eastwood, BJ; Priest, BT; Sher, E; Wilenkin, B; Williams, AC | 1 |
Huo, B; Jin, L; Li, H; Liu, R; Liu, S; Tang, L; Wang, Y; Yang, T; Zhang, F; Zhao, X | 1 |
Bartz, FM; Bednarski, PJ; Bodtke, A; Link, A; Schulig, L; Wurm, KW | 1 |
3 review(s) available for flupirtine and carbamates
Article | Year |
---|---|
Is there a role for potassium channel openers in neuronal ion channel disorders?
Topics: Aminopyridines; Animals; Anticonvulsants; Antihypertensive Agents; Ataxia; Carbamates; Diazoxide; Epilepsy; Humans; Ion Channels; Isaacs Syndrome; Membrane Potentials; Mice; Mice, Neurologic Mutants; Mutation; Nervous System Diseases; Neuroprotective Agents; Parkinson Disease; Phenylenediamines; Potassium Channels | 2000 |
Recent developments on KCNQ potassium channel openers.
Topics: Acrylamides; Aminopyridines; Benzamides; Carbamates; Epilepsy; Humans; Indoles; Ion Channel Gating; KCNQ Potassium Channels; KCNQ1 Potassium Channel; Migraine Disorders; Oxindoles; Pain; Phenylenediamines; Potassium Channels, Voltage-Gated | 2005 |
Molecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugs.
Topics: Aminopyridines; Animals; Binding Sites; Carbamates; Epilepsy, Benign Neonatal; Hearing Loss; Humans; KCNQ Potassium Channels; KCNQ1 Potassium Channel; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Phenylenediamines | 2008 |
17 other study(ies) available for flupirtine and carbamates
Article | Year |
---|---|
Flupirtine and retigabine prevent L-glutamate toxicity in rat pheochromocytoma PC 12 cells.
Topics: Aminopyridines; Analgesics; Animals; Antidepressive Agents; Carbamates; Cell Death; Clorgyline; Culture Media; Cystine; Dopamine Agents; Excitatory Amino Acid Antagonists; Glutamic Acid; Glutathione; Levodopa; Monoamine Oxidase; Monoamine Oxidase Inhibitors; PC12 Cells; Phenylenediamines; Rats; Reactive Oxygen Species; Receptors, N-Methyl-D-Aspartate | 2000 |
M channels containing KCNQ2 subunits modulate norepinephrine, aspartate, and GABA release from hippocampal nerve terminals.
Topics: Aminopyridines; Animals; Anthracenes; Anticonvulsants; Aspartic Acid; Carbamates; CHO Cells; Cricetinae; gamma-Aminobutyric Acid; Hippocampus; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Male; Norepinephrine; Patch-Clamp Techniques; Phenylenediamines; Potassium; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Presynaptic Terminals; Protein Subunits; Rats; Synaptosomes | 2004 |
Retigabine and flupirtine exert neuroprotective actions in organotypic hippocampal cultures.
Topics: Aminopyridines; Animals; Carbamates; Culture Media, Serum-Free; Glucose; Hippocampus; KCNQ Potassium Channels; N-Methylaspartate; Nerve Degeneration; Neuroprotective Agents; Oxygen; Phenylenediamines; Rats; Rats, Wistar; Reactive Oxygen Species; Receptors, N-Methyl-D-Aspartate; Tissue Culture Techniques | 2006 |
Molecular expression and pharmacological identification of a role for K(v)7 channels in murine vascular reactivity.
Topics: Aminopyridines; Animals; Anthracenes; Carbamates; Dose-Response Relationship, Drug; Gene Expression Profiling; Immunohistochemistry; Indoles; Isometric Contraction; KCNQ Potassium Channels; KCNQ1 Potassium Channel; Meclofenamic Acid; Mice; Mice, Inbred BALB C; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phenylenediamines; Potassium Channel Blockers; Potassium Channels; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; RNA | 2007 |
Bimodal effects of the Kv7 channel activator retigabine on vascular K+ currents.
Topics: Aminopyridines; Animals; Anthracenes; Carbamates; Dose-Response Relationship, Drug; In Vitro Techniques; KCNQ Potassium Channels; KCNQ1 Potassium Channel; Membrane Potentials; Mice; Mice, Inbred BALB C; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phenylenediamines; Portal Vein; Potassium; Potassium Channel Blockers; Recombinant Proteins; RNA, Messenger; Time Factors; Vasoconstriction; Vasodilator Agents; Xenopus laevis | 2008 |
The contribution of Kv7 channels to pregnant mouse and human myometrial contractility.
Topics: Aminopyridines; Animals; Anthracenes; Anticonvulsants; Carbamates; Female; Gene Expression; Gestational Age; Humans; KCNQ Potassium Channels; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Myometrium; Phenylenediamines; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Pregnancy; Protein Isoforms; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Uterine Contraction | 2011 |
Kv7 potassium channels in airway smooth muscle cells: signal transduction intermediates and pharmacological targets for bronchodilator therapy.
Topics: Aminopyridines; Animals; Anthracenes; Bronchoconstriction; Bronchodilator Agents; Calcium Channel Blockers; Carbamates; Celecoxib; Guinea Pigs; Histamine; Humans; KCNQ Potassium Channels; Male; Methacholine Chloride; Myocytes, Smooth Muscle; Patch-Clamp Techniques; Phenylenediamines; Pyrazoles; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Sulfonamides; Verapamil | 2012 |
Retigabine, a K(V)7 (KCNQ) potassium channel opener, attenuates L-DOPA-induced dyskinesias in 6-OHDA-lesioned rats.
Topics: Amantadine; Aminopyridines; Animals; Anticonvulsants; Antiparkinson Agents; Behavior, Animal; Carbamates; Dyskinesia, Drug-Induced; Female; Motor Activity; Oxidopamine; Phenylenediamines; Rats; Rats, Sprague-Dawley; Stereotyped Behavior | 2012 |
M channel enhancers and physiological M channel block.
Topics: Aminopyridines; Animals; Bradykinin; Calcium; Carbamates; CHO Cells; Cricetinae; Cricetulus; Ganglia, Spinal; Hydrogen Peroxide; Inflammation; KCNQ Potassium Channels; Organometallic Compounds; Pain; Phenylenediamines; Phosphatidylinositol 4,5-Diphosphate; Pyridines; Rats; Rats, Wistar; Sensory Receptor Cells; Type C Phospholipases | 2012 |
M-channels modulate network excitatory activity induced by 4-aminopyridine in immature rat substantia gelatinosa in vitro.
Topics: 4-Aminopyridine; Action Potentials; Aminopyridines; Analgesics; Animals; Animals, Newborn; Anthracenes; Biological Clocks; Biophysical Phenomena; Carbamates; Dose-Response Relationship, Drug; Drug Interactions; Female; In Vitro Techniques; Indoles; Male; Membrane Transport Modulators; Nerve Net; Neurons; Phenylenediamines; Potassium Channel Blockers; Pyridines; Rats; Rats, Wistar; Substantia Gelatinosa | 2013 |
Expression and motor functional roles of voltage-dependent type 7 K(+) channels in the human taenia coli.
Topics: Aged; Aged, 80 and over; Aminopyridines; Anthracenes; Carbamates; Colon; Gastrointestinal Motility; Gene Expression Regulation; Humans; In Vitro Techniques; KCNQ Potassium Channels; Middle Aged; Phenylenediamines; RNA, Messenger | 2013 |
KCNQ/Kv7 channel activator flupirtine protects against acute stress-induced impairments of spatial memory retrieval and hippocampal LTP in rats.
Topics: Aminopyridines; Animals; Anthracenes; Carbamates; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Long-Term Potentiation; Male; Maze Learning; Memory Disorders; Nootropic Agents; Phenylenediamines; Phosphorylation; Potassium Channel Blockers; Rats, Sprague-Dawley; Spatial Memory; Stress, Psychological | 2014 |
Expression and function of Kv7.4 channels in rat cardiac mitochondria: possible targets for cardioprotection.
Topics: Aminopyridines; Animals; Carbamates; KCNQ Potassium Channels; Male; Membrane Potentials; Mitochondria, Heart; Myocytes, Cardiac; Phenylenediamines; Potassium Channel Blockers; Rats | 2016 |
Targeting Kv7 channels in pain pathways.
Topics: Aminopyridines; Animals; Carbamates; Deafness; Epilepsy; Humans; Inflammation; KCNQ Potassium Channels; Long QT Syndrome; Mutation; Neurons; Pain; Pain Management; Phenylenediamines; Protein Conformation | 2017 |
Development of an Electrophysiological Assay for Kv7 Modulators on IonWorks Barracuda.
Topics: Aminopyridines; Carbamates; Cells, Cultured; Drug Development; Electrophysiological Phenomena; HEK293 Cells; High-Throughput Screening Assays; Humans; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Patch-Clamp Techniques; Phenylenediamines | 2019 |
Antinociceptive Efficacy of Retigabine and Flupirtine for Gout Arthritis Pain.
Topics: Aminopyridines; Analgesics; Animals; Arthritis, Experimental; Arthritis, Gouty; Behavior, Animal; Carbamates; Disease Models, Animal; Hyperalgesia; KCNQ Potassium Channels; Male; Pain; Phenylenediamines; Rats; Rats, Sprague-Dawley; Uric Acid | 2020 |
Carba Analogues of Flupirtine and Retigabine with Improved Oxidation Resistance and Reduced Risk of Quinoid Metabolite Formation.
Topics: Aminopyridines; Carbamates; KCNQ Potassium Channels; Phenylenediamines | 2022 |